The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $143.51

Today's change-0.81 -0.56%
Updated January 20 4:03 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $143.51

Today's change-0.81 -0.56%
Updated January 20 4:03 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc crosses below 20-day moving average

Thermo Fisher Scientific Inc closed lower Friday, dropping (U.S.)$0.81 or 0.56% to (U.S.)$143.51 and crossing below its 20-day moving average. Shares have lost 1.90% for the last five days, but have gained 7.86% over the last 52 weeks. This security has underperformed the S&P 500 by 14.30% during the last year.

Key company metrics

  • Open(U.S.) $144.91
  • Previous close(U.S.) $144.32
  • High(U.S.) $145.14
  • Low(U.S.) $143.32
  • Bid / Ask-- / --
  • YTD % change+1.71%
  • Volume1,750,006
  • Average volume (10-day)1,866,532
  • Average volume (1-month)1,744,347
  • Average volume (3-month)1,895,692
  • 52-week range(U.S.) $119.75 to (U.S.) $160.68
  • Beta1.09
  • Trailing P/E28.65×
  • P/E 1 year forward17.40×
  • Forward PEG1.60×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.42%
  • Trailing EPS(U.S.) $5.01
Updated January 20 4:03 PM EST. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Dec 31, 201512/31/2015
Revenue4,4914,5354,2954,653
Total other revenue--------
Total revenue4,4914,5354,2954,653
Gross profit2,0542,0791,9582,108
Total cost of revenue2,4372,4572,3372,544
Total operating expense3,9503,8983,7773,962
Selling / general / administrative1,2121,2191,1841,180
Research & development183182177180
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)117398058
Other operating expenses, total--------
Operating income541638518690
Interest income (expense), net non-operating-113-119-106-103
Gain (loss) on sale of assets--------
Other--------
Income before tax428521423583
Income after tax474517402606
Income tax, total-46421-24
Net income474517402603
Total adjustments to net income--------
Net income before extra. items474517402606
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items474517402606
Inc. avail. to common incl. extra. items474517402603
Diluted net income474517402603
Dilution adjustment--------
Diluted weighted average shares397397399403
Diluted EPS excluding extraordinary itemsvalue per share1.191.301.011.51
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.381.401.201.62